News & Blogs - Cognes

Every Hospital Needs this Alzheimer’s Diagnostic Test – Here’s Why

When it comes to Alzheimer’s diagnosis, getting an inexpensive and early diagnosis is one of the more challenging things to do in the medical field. This can leave both patients and hospitals feeling like they’re fighting an uphill battle against this disease. That’s why every hospital can benefit from this new and innovative Alzheimer’s diagnostic test.

What You Need to Know About Stevens Institute of Technology’s New AI Alzheimer’s Diagnosis Tool

Stevens Institute of Technology is one of the oldest technology universities in the United States. It is also amongst the first universities in the nation to enter the field of mechanical engineering. Since 1870, Stevens Institute of Technology’s research and development department has been significantly influential in terms of innovation in several fields.

How Cognes’ Self-Administered Alzheimer’s Test Can Help With Early Detection

The outlook for patients with Alzheimer’s disease relies on receiving an early and correct diagnosis, it is key for starting the appropriate treatment. For many families the current methods of diagnosis for Alzheimer’s disease available today are too expensive and unattainable, considering the time-consuming diagnostic procedures. In addition, current assessment tests are not always able to detect the disease at its earliest stages.

How Can MRI/PET-Scans Be Used For Biomarker Identifying?

Alzheimer’s disease is a very real condition that affects thousands of people across the world. For this reason, it is essential that doctors and scientists work together in order to find innovative ways in which to diagnose and treat this disease. Although there is no cure for this disease, doctors will be able to slow its progression and delay symptoms through various treatments.

Why Is Early Detection Of Alzheimer’s Disease So Important?

Brain disorders are the most difficult to deal with. Eventually, everything you do or can do is limited simply because one’s brain is deteriorating. One of the most talked-about brain disorders is Alzheimer’s disease. It is often caused by dementia and takes a toll on a lot of people.

Biogen’s FDA Approval For New Alzheimer’s Drug: What Does This Mean For Treatment Of The Disease?

Alzheimer’s disease is a progressive brain disorder that gradually disrupts a person’s memory and thinking skills. If left untreated, the disease may take over the person’s ability to carry out their everyday tasks. Alzheimer’s disease is widely known to be irreversible and typically occurs at the later stages of life- commonly starting from the mid-60s.

Every Hospital Needs this Alzheimer’s Diagnostic Test – Here’s Why

What You Need to Know About Stevens Institute of Technology’s New AI Alzheimer’s Diagnosis Tool

How Cognes’ Self-Administered Alzheimer’s Test Can Help With Early Detection

How Can MRI/PET-Scans Be Used For Biomarker Identifying?

Why Is Early Detection Of Alzheimer’s Disease So Important?

Biogen’s FDA Approval For New Alzheimer’s Drug: What Does This Mean For Treatment Of The Disease?

Main Menu

Get In Touch

Follow our journey